Monthly Archives: December 2017

Therapies for perianal fistulas in patients with Crohn’s disease (CD) are often ineffective in producing long-term healing. We performed a randomized placebo-controlled trial to determine the long-term efficacy and safety of a single local administra… Continue reading →

The innate immune system responds not only to bacterial signals, but also to non-infectious danger-associated molecular patterns that activate the NLRP3 inflammasome complex after tissue injury. Immune functions vary over the course of the day, but it … Continue reading →

This special issue of Gastroenterology provides in depth discussions of esophageal diseases with significant public health interest for which there have been substantial advances in recent years, including gastro-esophageal reflux disease, eosinophili… Continue reading →

Cytokinesis can fail during normal post-natal liver development, leading to polyploid hepatocytes. We investigated whether inhibiting cytokinesis in the liver; slows tumor growth without compromising the health of normal hepatocytes. We inhibited cytok… Continue reading →

Cell stress signaling pathways result in phosphorylation of the eukaryotic translation initiation factor 2 subunit alpha (EIF2S1 or EIF2A), which affects regulation of protein translation. Translation reprogramming mitigates stress by activating pathwa… Continue reading →

Inhibitors of the hepatitis C virus (HCV) NS5A protein are a key component of effective treatment regimens, but the genetic heterogeneity of HCV has limited the efficacy of these agents and mutations lead to resistance. We directly compared the efficac… Continue reading →

Pancreatic ductal adenocarcinoma (PDAC) is characterized by activated pancreatic stellate cells (PSCs), abundance of extracellular matrix (ECM), and production of cytokines and chemokines. Galectin 3 (GAL3), a β galactoside-specific lectin, contribute… Continue reading →

Central neuromodulators (antidepressants, antipsychotics and other CNS targeted medications) are increasingly used for treatment of functional GI disorders (FGIDs), now recognized as disorders of gut-brain interaction. However, the available evidence a… Continue reading →

Despite inducing an inflammatory response, Helicobacter pylori can persist in the gastric mucosa for decades. H pylori expression of cholesterol-α-glucosyltransferase (encoded by cgt) is required for gastric colonization and T-cell activation. We inve… Continue reading →

A system is needed to determine the risk of patients with Barrett’s esophagus for progression to high-grade dysplasia (HGD) and esophageal adenocarcinoma (EAC). We developed and validated a model to determine of progression to HGD or EAC in patients … Continue reading →